We turn nature’s DNA into new medicines for cancer
Science
Discovering novel medicines in the global metagenome and bringing them to patients
We are mining genomes to discover new medicines, including next-generation antibody drug conjugate (ADC) payloads for cancer.
Antibody Drug Conjugates
Leveraging evolution and computation for novel ADC payloads
Our platform combines powerful technologies in computation and chemistry. It has identified ADC payloads with mechanisms that are novel and orthogonal to existing payload mechanisms, opening the door to treating patient populations with major unmet needs.
Leadership
A world-class
interdisciplinary team
We are drug hunters, data scientists, biologists, chemists, and engineers united by a conviction that leveraging evolved medicines will improve outcomes for patients.